AstraZeneca makes ‘business decision’ to pull COVID-19 vaccine from Australia and EU
Vaxzevria had already been withdrawn from Australia's COVID-19 vaccine program.
The TGA has withdrawn approval for COVID-19 vaccine Vaxzevria on the request of its sponsor, AstraZeneca.
It finally closes a complex and controversial chapter in Australia’s COVID-19 vaccine rollout, which was initially structured around Vaxzevria: a viral vector vaccine and the only COVID-19 vaccine that Australia could manufacture onshore.
